222 related articles for article (PubMed ID: 24853275)
1. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.
Xu W; Kwon JH; Moon YH; Kim YB; Yu YS; Lee N; Choi KY; Kim YS; Park YK; Kim BW; Wang HJ
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1507-15. PubMed ID: 24853275
[TBL] [Abstract][Full Text] [Related]
2. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Jing Q; Jianyong L; Jiming Y; Shuren L; Rui W; Wei L
Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.
Dai CX; Gao Q; Qiu SJ; Ju MJ; Cai MY; Xu YF; Zhou J; Zhang BH; Fan J
BMC Cancer; 2009 Dec; 9():418. PubMed ID: 19948069
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Pinto E; Pelizzaro F; Cardin R; Battistel M; Palano G; Bertellini F; Kitenge MP; Peserico G; Farinati F; Russo FP
Dig Liver Dis; 2024 May; 56(5):872-879. PubMed ID: 37783655
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
11. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
12. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.
Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F
Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356
[TBL] [Abstract][Full Text] [Related]
15. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
16. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
18. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
19. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY
Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551
[TBL] [Abstract][Full Text] [Related]
20. The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma.
Wu X; Yang C; Yu H; Cao F; Shan Y; Zhao W
Medicine (Baltimore); 2019 Jul; 98(30):e16579. PubMed ID: 31348291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
